GxP Lifeline

  • 2020-bl-quality-excellence-03_132x132

    Solving Quality Problems: Go Beyond Root Cause to ‘Real’ Cause

    Extrapolating the root cause of a quality problem isn’t the same as determining the problem’s real cause. Learn how to discern real causes and avoid the cycle of recurring root cause investigations.

    Full story
  • business-professional-working-tech-132

    Quality Assurance and Quality Control: What's the Difference When It Comes to Managing Quality?

    Quality assurance and quality control aren’t identical or interchangeable. Comparing the two functions to television’s most enduring police crime drama might help you explain their differences to your peers.

    Full story
  • 2021-bl-implementing-a-qms_132x132

    10 Key Steps for Implementing a QMS

    Your company needs to an integrated, automated quality management system (QMS) to help you get your products to market faster and more efficiently. Where do you start? Consider these 10 steps to help you audit your current system and processes, get stakeholders onboard, and implement a QMS that will signifcantly improve your company's quality processes.

    Full story
  • 2021-bl-qarad-eifu_132x132

    Quality Inspiration: 5 Quality Quotes for Industry Professionals to Consider

    For professionals in the business of quality, inspiration can be found in all sorts of ways, from studying other industries to browsing the patent office or even taking a different route to work. A simple but often motivating approach is to look to words of wisdom from experts in their fields. Here are five insightful quotations, from a variety of fields, that carry quite a bit of truth for quality professionals.

    Full story
  • 2021-bl-fda-cosmetic-act_132x132

    Life Before Consumer Protection and the Food, Drug, and Cosmetic Act

    Before the Food, Drug, and Cosmetic Act of 1938, shopping could be hazardous to your health. The market was flooded with deceptive and dangerous products. The confidence we have today in food, drugs, medical devices, and cosmetics is largely due to the FD&C Act and the amendments that followed.

    Full story
  • Measuring Risk Management Outcomes

    The task of measuring the benefits risk management brings to an organization is a challenging one. To overcome this challenge, the measurement of risk management performance needs to consider a wide range of factors.

    Full story
  • Quality Is the Key Ingredient to Successful Manufacturing

    The president of Wellington Foods, a leading contract manufacturer of nutraceuticals, explains why quality should be an organization’s top priority. This approach helps manufacturers achieve better process control and plan for significant growth without worrying about highly complex manufacturing processes.

    Full story
  • 2019-bl-thumb-humans-and-robots-on-the-factory-floor

    The Future of Quality Is Artificial Intelligence

    Artificial intelligence (AI) isn’t just a cool tech trend. At the rate it’s going, it’s shaping the future of quality in the life sciences. Which is why we’ve designed a new data analytics solution that gives users complete control over their data and uses AI to drive decision-making.

    Full story
  • Future Trends and Opportunities in Quality Assurance

    At a previous PDA/FDA Joint Regulatory Conference in Washington, D.C, Donna Gulbinski, quality and regulatory affairs expert, provided useful information about the future of quality management. She identified some key strategies for how your organization can identify and understand quality assurance trends and develop initiatives for long-term success.

    Full story
  • 2020-bl-brian-curran-10-talk_132x132

    Three Quality Management Trends to Watch in 2021

    Three key trends in MedTech quality management for 2021 include a rise in eQMS adoption, the continuation of remote audits and an increase in shared supplier audits.

    Full story
  • 2020-bl-sscp-eumdr_132x132

    EU’s MDR Calls for Summary of Safety and Clinical Performance (SSCP)

    With the fast-approaching Medical Devices Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR), medical device manufacturers will be seeing more documentation requirements. One of the new documents is a summary of safety and clinical performance (SSCP). This is one of the annual reports manufacturers must provide throughout the life cycle of a device in order to remain compliant to sell products in the EU.

    Full story
  • 2020-bl-manufacturing-day_132x132

    The Next Evolution in Manufacturing

    On 30 July 2020, we celebrated the 17th anniversary of the completion of the Human Genome Project (HGP). It took scientists 13 years to map and sequence all human genes, a staggering feat of modern science.

    Full story
  • 2020-bl-connected-quality-effective-training_132x132

    What Connected Quality Means for Training

    For regulated companies, there’s a whole lot riding on training. If someone isn’t trained or is trained improperly, the life-saving products of life sciences companies can become life-ending products.

    Full story
  • 2020-bl-digital-tools-enhance-supplier-management-capability_132x32

    The Platform Advantage: Keys to Keeping Up With Pharma’s Top 4 Trends

    To keep pace with the technological and scientific advancements that continue to shake up the pharmaceutical industry, companies are increasingly finding it necessary to adapt their strategies, procedures and business practices.

    Full story
  • 2020-bl-cloud-ultimate-guide2_132x132

    Cloud based QMS Launches in Australia

    MasterControl’s cloud-based quality management system (QMS) is now available in Australia. An increasing number of businesses are modernising their operations and discovering the advantages of cloud computing. Explore the ways cloud technology makes it possible to enhance your competitive edge.

    Full story
  • 2020-bl-thumb-8-system-requirements-ext-quality-across-ecosystems

    Top Regulatory Trends Affecting Med Dev in Asia-Pacific Moving Into 2019

    Despite a virtual kaleidoscope of continual regulatory fluctuations, 2019 presents some potentially very attractive market expansion opportunities in Asia-Pacific, including China, India, Australia and Japan. Get a comprehensive overview of device markets and their promising potential.

    Full story
  • 2020-bl-thumb-3-medical-device-trends

    What Do Changes to Australia’s PIC/S Guide to GMP Mean for Pharma Down Under?

    It’s said that change is never easy. But in the pharmaceutical industry, flexibility, and adaptability are part and parcel of successfully delivering the safest, highest quality products to a global market.

    Full story
  • 2020-bl-therapeutic-goods-admin-guidance_132x132

    Software as a Medical Device – Upcoming Changes to the Australian Regulations

    So much can change over a nearly 20 year period. Since the Australian Regulatory Framework for medical devices was adopted in 2002, the use and accessibility of software in medical applications has advanced beyond expectation.

    Full story
[ { "key": "fid#1", "value": ["GxP Lifeline Blog"] } ]